The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Tau Cleavage and Dephosphorylation in Cerebellar Granule Neurons Undergoing Apoptosis
Open accessAbstract
Cerebellar granule cells undergo apoptosis in culture after deprivation of potassium and serum. During this process we found that tau, a neuronal microtubule-associated protein that plays a key role in the maintenance of neuronal architecture, and the pathology of which correlates with intellectual decline in Alzheimer’s disease, is cleaved. The final product of this cleavage is a soluble dephosphorylated tau fragment of 17 kDa that is unable to associate with microtubules and accumulates in the perikarya of dying cells. The appearance of this 17 kDa fragment is inhibited by both caspase and calpain inhibitors, suggesting that tau is an in vivo substrate for both of these proteases during apoptosis. Tau cleavage is correlated with disruption of the microtubule network, and experiments with colchicine and taxol show that this is likely to be a cause and not a consequence of tau cleavage. These data indicate that tau cleavage and change in phosphorylation are important early factors in the failure of the microtubule network that occurs during neuronal apoptosis. Furthermore, this study introduces new insights into the mechanism(s) that generate the truncated forms of tau present in Alzheimer’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, calpain A has been shown to cleave tau and is reported to be responsible for producing a 17 kDa fragment that may be a highly toxic tau derivative (211,212).”
From Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation (2011) · cites this paper as [212]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,311
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,980
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524
Caspases: the executioners of apoptosis
Cohen, G. M. (1997) · Biochemical Journal · doi:10.1042/bj3260001 · Cited by 4,737
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Mechanisms and Genes of Cellular Suicide
Steller, H. (1995) · Science · doi:10.1126/science.7878463 · Cited by 2,469
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780
Research works printed but not linked: 2
- Fasulo, 1998, Tau truncation in Alzheimer’s disease: expression of a fragment encompassing PHF core tau induces apoptosis in COS cells., Alzheimer’s Rep, 1, 1
- 10.1128/MCB.9.4.1381 · DOI
Cited by
Sorted by citations
Apoptosis: controlled demolition at the cellular level
Taylor, R. C., Cullen, S. P., & Martin, S. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2312 · Cited by 2,708
Roles of tau protein in health and disease
Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003
Many cuts to ruin: a comprehensive update of caspase substrates
Fischer, U., Jänicke, R. U., & Schulze‐Osthoff, K. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401160 · Cited by 1,025
Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies
Ciechanover, A., & Kwon, Y. T. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.117 · Cited by 898
Calpain and caspase: can you tell the difference?
Wang, K. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01479-4 · Cited by 912
Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
Gamblin, T. C., Chen, F., Zambrano, A., Abraha, A., Lagalwar, S., Guillozet, A. L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630428100 · Cited by 831
Post-translational modifications of tau protein: Implications for Alzheimer's disease
Martin, L., Latypova, X., & Terro, F. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2010.12.023 · Cited by 683
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology
Rissman, R. A., Poon, W. W., Blurton-Jones, M., Oddo, S., Torp, R., Vitek, M. P., LaFerla, F. M., Rohn, T. T., & Cotman, C. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420640 · Cited by 543
Structure and Pathology of Tau Protein in Alzheimer Disease
Kolarova, M., García‐Sierra, F., Bartoš, A., Říčný, J., & Řípová, D. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/731526 · Cited by 526
Synergistic Activation of Caspase-3 by m-Calpain after Neonatal Hypoxia-Ischemia
Blomgren, K., Zhu, C., Wang, X., Karlsson, J., Leverin, A., Bahr, B. A., Mallard, C. E., & Hagberg, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007807200 · Cited by 447
Tau, tangles, and Alzheimer's disease
Binder, L. I., Guillozet-Bongaarts, A. L., García‐Sierra, F., & Berry, R. W. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.08.014 · Cited by 450
Yamashima, T. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00006-x · Cited by 346
Moloney, C. M., Lowe, V. J., & Murray, M. E. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12321 · Cited by 358
Proteasomal degradation of tau protein
David, D. C., Layfield, R., Serpell, L., Narain, Y., Goedert, M., & Spillantini, M. G. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01137.x · Cited by 327
C-terminal inhibition of tau assembly in vitro and in Alzheimer’s disease
Abraha, A., Ghoshal, N., Gamblin, T. C., Cryns, V. L., Berry, R. W., Kuret, J., & Binder, L. I. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.21.3737 · Cited by 326
Andreadis, A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.08.010 · Cited by 311
Guo, H., Albrecht, S., Bourdeau, M., Petzke, T., Bergeron, C., & LeBlanc, A. C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63317-2 · Cited by 287
Park, S.-Y., & Ferreira, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1125-05.2005 · Cited by 262
Su, J. H., Zhao, M., Anderson, A. J., Srinivasan, A. N., & Cotman, C. W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02018-2 · Cited by 260
Tau truncation during neurofibrillary tangle evolution in Alzheimer’s disease
Guillozet-Bongaarts, A. L., Garcia-Sierra, F., Reynolds, M. R., Horowitz, P. M., Fu, Y., Wang, T., Cahill, M. E., Bigio, E. H., Berry, R. W., & Binder, L. I. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.019 · Cited by 256
Žilka, N., Filipčík, P., Koson, P., Fialová, Ľ., Škrabana, R., Žilková, M., Rolkova, G., Kontseková, E., & Novák, M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.05.029 · Cited by 254
Rho GTPase signalling pathways in the morphological changes associated with apoptosis
Coleman, M. L., & Olson, M. F. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400987 · Cited by 250
NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation
Amadoro, G., Ciotti, M. T., Costanzi, M., Cestari, V., Calissano, P., & Canu, N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511065103 · Cited by 243
Self-citationCaspase-9 Activation and Caspase Cleavage of tau in the Alzheimer's Disease Brain
Rohn, T. T., Rissman, R. A., Davis, M. C., Kim, Y., Cotman, C. W., & Head, E. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0549 · Cited by 248
Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease.
Chesser, A. S., Pritchard, S. M., & Johnson, G. V. W. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00122 · Cited by 219
Early N-Terminal Changes and Caspase-6 Cleavage of Tau in Alzheimer's Disease
Horowitz, P. M., Patterson, K. R., Guillozet-Bongaarts, A. L., Reynolds, M. R., Carroll, C. A., Weintraub, S. T., Bennett, D. A., Cryns, V. L., Berry, R. W., & Binder, L. I. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1988-04.2004 · Cited by 215
Contestabile, A. (2002) · The Cerebellum · doi:10.1080/147342202753203087 · Cited by 221
Proapoptotic Effects of Tau Cleavage Product Generated by Caspase-3
Chung, C.-W., Song, Y.-H., Kim, I.-K., Yoon, W. J., Ryu, B. R., Jo, D., Woo, H., Kwon, Y.-K., Kim, H., Gwag, B.-J., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0335 · Cited by 211
Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?
Dickson, D. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22317 · Cited by 212
The Role of Caspase Cleavage of Tau in Alzheimer Disease Neuropathology
Cotman, C. W., Poon, W. W., Rissman, R. A., & Blurton-Jones, M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.104 · Cited by 199
Tapia‐Rojas, C., Cabezas-Opazo, F., Deaton, C. A., Vergara, E. H., Johnson, G. V. W., & Quintanilla, R. A. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.005 · Cited by 207
Fasulo, L., Ugolini, G., Visintin, M., Bradbury, A. M., Brancolini, C., Verzillo, V., Novák, M., & Cattaneo, A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750624.x · Cited by 195
Self-citationProcaspase-3 and Poly(ADP)ribose Polymerase (PARP) Are Calpain Substrates
McGinnis, K., Gnegy, M. E., Park, Y. H., Mukerjee, N., & Wang, K. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1315 · Cited by 179
Activation of Caspase-8 in the Alzheimer's Disease Brain
Rohn, T. T., Head, E., Nesse, W. H., Cotman, C. W., & Cribbs, D. H. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0449 · Cited by 171
Guillozet-Bongaarts, A. L., Cahill, M. E., Cryns, V. L., Reynolds, M. R., Berry, R. W., & Binder, L. I. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03784.x · Cited by 180
Proteins released from degenerating neurons are surrogate markers for acute brain damage
Siman, R., McIntosh, T. K., Soltesz, K., Chen, Z., Neumar, R. W., & Roberts, V. L. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.03.016 · Cited by 164
Limorenko, G., & Lashuel, H. A. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00127b · Cited by 168
Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration
Maria Jose Perez, J., Jara, C., & Quintanilla, R. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00441 · Cited by 157
Higuchi, M., Tomioka, M., Takano, J., Shirotani, K., Iwata, N., Masumoto, H., Maki, M., Itohara, S., & Saido, T. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500939200 · Cited by 152
Funk, K. E., Thomas, S. N., Schafer, K. N., Cooper, G. L., Liao, Z., Clark, D. J., Yang, A. J., & Kuret, J. (2014) · Biochemical Journal · doi:10.1042/bj20140372 · Cited by 142
The Induction of the TNFα Death Domain Signaling Pathway in Alzheimer's Disease Brain
Zhao, M., Cribbs, D. H., Anderson, A. J., Cummings, B. J., Su, J. H., Wasserman, A., & Cotman, C. W. (2003) · Neurochemical Research · doi:10.1023/a:1022337519035 · Cited by 149
Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease
Chong, Z. Z., Li, F., & Maiese, K. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.11.005 · Cited by 152
Basurto‐Islas, G., Luna‐Muñoz, J., Guillozet-Bongaarts, A. L., Binder, L. I., Mena, R., & García‐Sierra, F. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31817275c7 · Cited by 163
From Alzheimer to Huntington: why is a structural understanding so difficult?
Temussi, P. A., Masino, L., & Pastore, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg044 · Cited by 147
Canu, N., Barbato, C., Ciotti, M. T., Serafino, A., Dus, L., & Calissano, P. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00589.2000 · Cited by 144
Self-citationMolecular mechanisms of ionizing radiation‐induced apoptosis
Watters, D. J. (1999) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.1999.00824.x · Cited by 138
Wang, Y., Garg, S., Mandelkow, E., & Mandelkow�, E. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380955 · Cited by 145
Ando, K., Brion, J.-P., Stygelbout, V., Suain, V., Authelet, M., Dedecker, R., Chanut, A., Lacor, P., Lavaur, J., Sazdovitch, V., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1111-z · Cited by 136
Quantitative proteomics reveals distinct composition of amyloid plaques in Alzheimer’s disease
Xiong, F., Ge, W., & Ma, C. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.10.006 · Cited by 133
Brioni, J. D., Esbenshade, T. A., Garrison, T. R., Bitner, S. R., & Cowart, M. (2010) · Cited by 125
Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia
Stanford, P. M. (2003) · Brain · doi:10.1093/brain/awg090 · Cited by 125
Current status of fluid biomarkers in mild traumatic brain injury
Kulbe, J. R., & Geddes, J. W. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.05.004 · Cited by 128
Analysis of Tau Phosphorylation and Truncation in a Mouse Model of Human Tauopathy
Delobel, P., Lavenir, I., Fraser, G. M., Ingram, E., Holzer, M., Ghetti, B. F., Spillantini, M. G., Crowther, R. A., & Goedert, M. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070627 · Cited by 124
Anti-Apoptotic Effects of Carotenoids in Neurodegeneration
Park, H., Hayden, M. M., Bannerman, S., Jansen, J., & Crowe-White, K. M. (2020) · Molecules · doi:10.3390/molecules25153453 · Cited by 127
Fifre, A., Sponne, I., Koziel, V., Kriem, B., Yen, F. T., Bihain, B. E., Olivier, J. L., Oster, T., & Pillot, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507378200 · Cited by 124
Transgenic zebrafish model of neurodegeneration
Tomasiewicz, H. G., Flaherty, D. B., Soria, J., & Wood, J. G. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10451 · Cited by 117
Rami, A., Agarwal, R., Botez, G., & Winckler, J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02301-5 · Cited by 115
Ambegaokar, S. S., & Jackson, G. R. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr432 · Cited by 113
“Indeed, calpain A has been shown to cleave tau and is reported to be responsible for producing a 17 kDa fragment that may be a highly toxic tau derivative (211,212).”
BackgroundThe role of caspases in Alzheimer’s disease; potential novel therapeutic opportunities
Rohn, T. T. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0463-2 · Cited by 112
Apoptosis and in vitro Alzheimer’s disease neuronal models
Calissano, P., Matrone, C., & Amadoro, G. (2009) · Communicative & Integrative Biology · doi:10.4161/cib.7704 · Cited by 111
Self-citationWingrave, J. M., Schaecher, K. E., Sribnick, E. A., Wilford, G. G., Ray, S. K., Hazen‐Martin, D. J., Hogan, E. L., & Banik, N. L. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10607 · Cited by 110
Recent advances on neuronal caspases in development and neurodegeneration
Marks, N., & Berg, M. J. (1999) · Neurochemistry International · doi:10.1016/s0197-0186(99)00061-3 · Cited by 109
Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment
Garg, S., Timm, T., Mandelkow, E.-M., Mandelkow, E., & Wang, Y. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.09.008 · Cited by 103
Caspases as Targets for Anti-Inflammatory and Anti-Apoptotic Drug Discovery
Talanian, R. V., Brady, K. D., & Cryns, V. L. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000060f · Cited by 102
Truncation of Tau Protein and its Pathological Significance in Alzheimer's Disease
García‐Sierra, F., Mondragón‐Rodríguez, S., & Basurto‐Islas, G. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14407 · Cited by 109
Galas, M.-C., Dourlen, P., Bégard, S., Ando, K., Blum, D., Hamdane, M., & Buée, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601849200 · Cited by 97
Zhao, M., Su, J. H., Head, E., & Cotman, C. W. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.07.006 · Cited by 97
The Role of Tau in Neurodegenerative Diseases and Its Potential as a Therapeutic Target
Wolfe, M. S. (2012) · Scientifica · doi:10.6064/2012/796024 · Cited by 105
Meske, V., Albert, F., Richter, D., Schwarze, J., & Ohm, T. G. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02433.x · Cited by 94
Suen, K.-C., Yu, M.-S., So, K.-F., Chang, R. C.-C., & Hugon, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306503200 · Cited by 95
Neurodegeneration in Alzheimer's disease: caspases and synaptic element interdependence
Bredesen, D. E. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-27 · Cited by 103
Atlante, A., Amadoro, G., Bobba, A., Lidia de, B. A. R. I., Corsetti, V., Pappalardo, G., Marra, E., Calissano, P., & Passarella, S. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.07.004 · Cited by 93
Self-citationMolecular basis of Alzheimer's disease
Drouet, B., Pinçon‐Raymond, M., Chambaz, J., & Pillot, T. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050035 · Cited by 96
Nerve Growth Factor and Alzheimer's Disease: New Facts for an Old Hypothesis
Cattaneo, A., & Calissano, P. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8310-9 · Cited by 93
Self-citationCell-based Models To Investigate Tau Aggregation
Lim, S., Haque, M. M., Kim, D., Kim, D. J., & Kim, Y. K. (2014) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2014.09.011 · Cited by 91
Discovering New Treatments for Alzheimer's Disease by Repurposing Approved Medications
Appleby, B. S., & Cummings, J. L. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113136660162 · Cited by 78
Elyaman, W., Terro, F., Wong, N. S., & Hugon, J. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01899.x · Cited by 79
Johnson, G. V. W., & Bailey, C. D. C. (2002) · Journal of Alzheimer's Disease · doi:10.3233/jad-2002-4505 · Cited by 61
Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease
Iqbal, K., Gong, C., & Liu, F. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.870156 · Cited by 76
Beyond the Signal Sequence: Protein Routing in Health and Disease
Castro-Fernández, C., Maya‐Núñez, G., & Conn, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2004-0010 · Cited by 73
Misregulation of Tau Alternative Splicing in Neurodegeneration and Dementia
Andreadis, A. (2006) · Progress in molecular and subcellular biology · doi:10.1007/978-3-540-34449-0_5 · Cited by 72
Tau Phosphorylation and Cleavage in Ethanol-Induced Neurodegeneration in the Developing Mouse Brain
Saito, M., Chakraborty, G., Mao, R.-F., Paik, S.-M., Vadász, C., & Saito, M. (2010) · Neurochemical Research · doi:10.1007/s11064-009-0116-4 · Cited by 72
Higuchi, M., Iwata, N., & Saido, T. C. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.02.013 · Cited by 73
Kim, B., Backus, C., Oh, S., & Feldman, E. L. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121669 · Cited by 74
García‐Sierra, F., Wischik, C. M., Harrington, C. R., Luna‐Muñoz, J., & Mena, R. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00096-5 · Cited by 72
Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons
Amadoro, G., Serafino, A., Barbato, C., Ciotti, M. T., Sacco, A., Calissano, P., & Canu, N. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401314 · Cited by 69
Self-citationKulbe, J. R., & Hall, E. D. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.08.003 · Cited by 70
Tau phosphorylation and proteolysis: Insights and perspectives
Johnson, G. V. W. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s326 · Cited by 69
Bobba, A., Atlante, A., Giannattasio, S., Sgaramella, G., Calissano, P., & Marra, E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01018-2 · Cited by 68
Self-citationLinking Alterations in Tau Phosphorylation and Cleavage during Neuronal Apoptosis
Rametti‐Lacroux, A., Esclaire, F., Yardin, C., & Terro, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408186200 · Cited by 64
Corsetti, V., Amadoro, G., Gentile, A., Capsoni, S., Ciotti, M. T., Cencioni, M. T., Atlante, A., Canu, N., Rohn, T. T., Cattaneo, A., et al. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.03.011 · Cited by 68
Self-citationWarren, M. W., Kobeissy, F. H., Liu, M. C., Hayes, R. L., Gold, M. S., & Wang, K. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.058 · Cited by 64
Intracellular and Extracellular Roles for Tau in Neurodegenerative Disease
Hanger, D. P., Lau, D. H. W., Phillips, E. C., Bondulich, M. K., Guo, T., Woodward, B. W., Pooler, A. M., & Noble, W. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132054 · Cited by 66
Rohn, T. T., Cusack, S. M., Kessinger, S. R., & Oxford, J. T. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.12.029 · Cited by 62
Sahara, N., Murayama, M., Lee, B., Park, J., Lagalwar, S., Binder, L. I., & Takashima, A. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06258.x · Cited by 63
Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target
Oakley, S. S., Maina, M. B., Marshall, K. E., Al‐Hilaly, Y. K., Harrington, C., Wischik, C. M., & Serpell, L. C. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.590754 · Cited by 59
Tau cleavage and tau aggregation in neurodegenerative disease
Hanger, D. P., & Wray, S. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381016 · Cited by 60
Tau Function and Dysfunction in Neurons
Ávila, J., Lim, F., Moreno, F. J., Belmonte, C., & Cuello, A. C. (2002) · Molecular Neurobiology · doi:10.1385/mn:25:3:213 · Cited by 63
Liu, M. C., Kobeissy, F. H., Zheng, W., Zhang, Z., Hayes, R. L., & Wang, K. (2010) · ASN NEURO · doi:10.1042/an20100012 · Cited by 59
Mondragón‐Rodríguez, S., Mena, R., Binder, L. I., Smith, M. A., Perry, G. L., & García‐Sierra, F. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00853.x · Cited by 60
Metadata
- Authors
- Canu, N., Dus, L., Barbato, C., Ciotti, M. T., Brancolini, C., Rinaldi, A. M., Novak, M., Cattaneo, A., Bradbury, A., & Calissano, P.
- Affiliations
- University of Rome Tor Vergata (IT)
- Institute of Neurobiology and Molecular Medicine (IT)
- AREA Science Park (IT)
- Scuola Internazionale Superiore di Studi Avanzati (IT)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1998-09-15
- Volume
- 18
- Issue
- 18
- Pages
- 7061-7074
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6793249
- OpenAlex
- W2122437043
- Cited by
- 232
- References
- 71
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 1 · 2022: 4 · 2021: 3 · 2020: 6 · 2019: 6 · 2018: 13 · 2017: 7 · 2016: 3 · 2015: 7 · 2014: 13 · 2013: 9 · 2012: 6
- FWCI
- 8.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, other-oa)
- Institutional Research Information System (University of Udine) (submittedVersion)
- Scuola Normale Superiore di Pisa (submittedVersion)
- Funders
- Consiglio Nazionale delle Ricerche
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- tau protein, tau cleavage, tau dephosphorylation, cerebellar granule cells, neuronal apoptosis, caspases, calpain, microtubule-associated proteins, Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Animals, Antineoplastic Agents, Phytogenic, Calpain, Cerebellum, Colchicine, Cysteine Endopeptidases, Cytoskeleton, Enzyme Precursors, Microtubules, Neurons, Oligopeptides, Peptide Fragments, Phosphorylation, Solubility, Cysteine Proteinase Inhibitors, tau Proteins, Rats, Wistar, Apoptosis, Paclitaxel, Caspases, Rats, Caspase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review